A review on cholinesterase inhibitors for Alzheimer's disease

P Anand, B Singh - Archives of pharmacal research, 2013 - Springer
Abstract Alzheimer's disease (AD), a progressive neurodegenerative disorder, is
characterized by the deficits in the cholinergic system and deposition of beta amyloid (Aβ) in …

Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection

M Singh, M Kaur, H Kukreja, R Chugh, O Silakari… - European journal of …, 2013 - Elsevier
Acetylcholinesterase is a member of the α/β hydrolase protein super family, with a significant
role in acetylcholine-mediated neurotransmission. Research in the modulators of AChEs …

[HTML][HTML] Arylcarboxylation of unactivated alkenes with CO2 via visible-light photoredox catalysis

W Zhang, Z Chen, YX Jiang, LL Liao, W Wang… - Nature …, 2023 - nature.com
Photocatalytic carboxylation of alkenes with CO2 is a promising and sustainable strategy to
synthesize high value-added carboxylic acids. However, it is challenging and rarely …

Conformational restriction: an effective tactic in'follow-on'-based drug discovery

Z Fang, Y Song, P Zhan, Q Zhang… - Future medicinal …, 2014 - Taylor & Francis
The conformational restriction (rigidification) of a flexible ligand has often been a commonly
used strategy in drug design, as it can minimize the entropic loss associated with the ligand …

Cholinesterase inhibitors for Alzheimer's disease: multitargeting strategy based on anti-Alzheimer's drugs repositioning

MT Kabir, MS Uddin, M Begum… - Current …, 2019 - ingentaconnect.com
In the brain, acetylcholine (ACh) is regarded as one of the major neurotransmitters. During
the advancement of Alzheimer's disease (AD) cholinergic deficits occur and this can lead to …

Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015)

SF McHardy, HYL Wang, SV McCowen… - Expert opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: Acetylcholinesterase (AChE) is the major enzyme that hydrolyzes
acetylcholine, a key neurotransmitter for synaptic transmission, into acetic acid and choline …

Amyloid–cholinesterase interactions: implications for Alzheimer's disease

NC Inestrosa, MC Dinamarca, A Alvarez - The FEBS journal, 2008 - Wiley Online Library
Acetylcholinesterase is an enzyme associated with senile plaques. Biochemical studies
have indicated that acetylcholinesterase induces amyloid fibril formation by interaction …

[HTML][HTML] A comprehensive review of cholinesterase modeling and simulation

D De Boer, N Nguyen, J Mao, J Moore, EJ Sorin - Biomolecules, 2021 - mdpi.com
The present article reviews published efforts to study acetylcholinesterase and
butyrylcholinesterase structure and function using computer-based modeling and simulation …

Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment

A Musial, M Bajda, B Malawska - Current medicinal chemistry, 2007 - ingentaconnect.com
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the central
nervous system (CNS) which is the most common cause of dementia in the elderly. It is …

A small molecule targeting the multifactorial nature of Alzheimer's disease

A Cavalli, ML Bolognesi, S Capsoni… - ANGEWANDTE …, 2007 - cris.unibo.it
Alzheimer s disease (AD) is a complex multifactorial syndrome unlikely to arise from a single
causal factor, but due to a number of different but related biological alterations that …